New meetings & grants, with a focus on Vietnam, China, and the UK

Dear All: Below my signature, find details of 4 new meetings and (collectively) 4 active or upcoming grant opportunities. One of the grants has a 6 Sep deadline, so look quickly! At the very bottom of the email you will find an integrated summary of all upcoming meetings … there is a lot going on!

I hope to see you at next week’s ASM-ESCMID conference for the first episodes of the CARB-Xed + GARDP Bootcamp for Developers Series. Until then, all best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Chief Strategy Officer, CARB-X | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: http://amr.solutions/blog/

 ————————————-
Meetings, two of which are preludes to grant competitions

  • 1 Oct 2017 and 2 Nov 2017 (London): BSAC: AMR Market Lounges. A pair of networking days focused on solutions to the AMR challenge.
  • 10 Oct 2017 (Hanoi): UK-Vietnam Newton Fund Pre-Call Workshop on Partnership for Infectious Disease Research 2017. This is a workshop in Hanoi in advance of a call for Newton Fund*-supported proposals from the collaboration between UK MRC and the -Vietnamese Ministry of Science and Technology (MOST).
  • 20 Nov 2017 (that week, in China): UK-China Newton Fund Workshop: Antimicrobial Resistance Centre Partnerships Initiative. This is a workshop in China in advance of a call for Newton Fund*-supported proposals from the collaboration between Research Councils UK (RCUK) and the National Natural Science Foundation of China (NSFC).
  • 20 Nov 2017 (London): Early Career Researcher Workshop on Diagnostics for Antimicrobial Resistance. This will be a one-day workshop for early career researchers which will include invited experts “to provide inspiration, encourage interdisciplinary networking, and explore the barriers and opportunities facing the development of rapid diagnostics for infectious disease.”

*The Newton Fund builds scientific and innovation partnerships with 16 partner countries to support their economic development and social welfare, and to develop their research and innovation capacity for long-term sustainable growth. It has a total UK Government investment of £735 million up until 2021, with matched resources from the partner countries. The Newton Fund is managed by the UK Department for Business, Energy and Industrial Strategy (BEIS), and delivered through 15 UK Delivery Partners, which include the Research Councils, the UK National Academies, the British Council, Innovate UK and the Met Office.

​ ————————————-
Other grant opportunities

​ ————————————-
Integrated summary of upcoming meetings of interest to the AMR community:

Share

How economists (and Finance Ministers) think…

Dear All, Anthony McDonnell and his colleagues at CGD (Center for Global Development) have just released a truly lovely paper on the economics of antibiotic resistance. What makes this one special is that the paper dissects the problem of AMR through an economist’s spectacles in a way that is very accessible to the non-expert. You

The road to UNGA 2024 is paved with … reports!

Dear All, We’re now well into the run-up to the HLM (High-Level Meeting) on AMR during UNGA 2024 (the UN General Assembly, September 2024, see the 15 Apr 2023 newsletter for details). In preparation, reports providing data to support policy and decision-making are continuing to appear. Today, for example, GCOA and IDSA released their report entitled “2024

Leaving the lab: The decline in AMR R&D professionals

Dear All, The AMR Industry Alliance has today released a fascinating and disturbing report. Entitled “Leaving the Lab: Tracking the Decline in AMR R&D Professionals” (press release, report itself), its key message of “Researchers Are Leaving the AMR Field – Even as the Threat Rapidly Grows” is illustrated vividly by the report’s graphics. I’m going

ADVANCE-ID seeks antibiotic for P2/3 development Asia!

Dear All, Yow! Led by David Paterson,  ADVANCE-ID (ADVANcing Clinical Evidence in Infectious Diseases) is a research group launched March 2023 as a network of more than 30 hospitals across Asia. The exciting news is that ADVANCE-ID have just announced that they are seeking a novel antimicrobial agent vs. MDR Gram-negatives that could be advanced in the clinic

Scroll to Top